The epidemiology of sex chromosome abnormalities
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Sex chromosome abnormalities (SCAs) are characterized by gain or loss of entire sex chromosomes or parts of sex chromosomes with the best‐known syndromes being Turner syndrome, Klinefelter syndrome, 47,XXX syndrome, and 47,XYY syndrome. Since these syndromes were first described more than 60 years ago, several papers have reported on diseases and health related problems, neurocognitive deficits, and social challenges among affected persons. However, the generally increased comorbidity burden with specific comorbidity patterns within and across syndromes as well as early death of affected persons was not recognized until the last couple of decades, where population‐based epidemiological studies were undertaken. Moreover, these epidemiological studies provided knowledge of an association between SCAs and a negatively reduced socioeconomic status in terms of education, income, retirement, cohabitation with a partner and parenthood. This review is on the aspects of epidemiology in Turner, Klinefelter, 47,XXX and 47,XYY syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979 · cited 2×
“There is evidence that UK Biobank participants were less likely to live in socioeconomically deprived areas than nonparticipants (Fry et al., 2017), and an association between 47,XXX syndrome and lower socioeconomic status has been shown (Stochholm, Juul, & Gravholt, 2013).”
BackgroundNielsen, J., & Wohlert, M. (1991) · Human Genetics · doi:10.1007/bf01213097 · Cited by 1,193 · cited 5×
“…(Bochkov, Kuleshov, Chebotarev, Alekhin, & Midian, 1974; Hamerton, Canning, Ray, & Smith, 1975; Jacobs, Melville, Ratcliffe, Keay, & Syme, 1974; Nielsen & Wohlert, 1991), KS: 152 per 100,000 males (1 per 658 males) (84 KS among 55,212 newborn males) (Bochkov et al., 1974; Hamerton et al.,…”
BackgroundInfluentialGravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0430 · Cited by 1,101 · cited 6×
“neck webbing and lymphedema, primary or secondary amenorrhea, and cardiac malformations) (Gravholt et al., 2017), and also a somewhat more precise phenotype in KS (tall stature, small testes, hyper-”
BackgroundSelf-citationPrenatal and postnatal prevalence of Klinefelter syndrome: a national registry study
Bojesen, A., Juul, S., & Gravholt, C. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021491 · Cited by 894
Self-citationA cytogenetic survey of 14,069 newborn infants: I. Incidence of chromosome abnormalities
Hamerton, J. L., Canning, N., Ray, M., & Smith, S. (1975) · Clinical Genetics · doi:10.1111/j.1399-0004.1975.tb01498.x · Cited by 565
Gravholt, C. H., Juul, S., Naeraa, R. W., & Hansen, J. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00237-0 · Cited by 548 · cited 6×
“In a study of all females diagnosed with TS during 1960–1992 (n = 594) and the Danish female population (n = 2,594,036 females), the incidence of diseases suspected to occur with increased frequency in TS were compared using relative risk (RR) as the measure of association (Gravholt et al., 1998).”
BackgroundMethodResultInfluentialIncidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA
Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., & Warren, S. T. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.007 · Cited by 436 · cited 1×
“In a large screening study from Georgia, United States of America, 2009, DNA from dried blood spots from 36,124 newborn boys showed a prevalence of 158 KS per 100,000 newborn males (1 per 632) (Coffee et al., 2009).”
BackgroundMortality in women with Turner syndrome in Great Britain: a national cohort study
Schoemaker, M. J., Swerdlow, A. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1049 · Cited by 360 · cited 10×
“Among a British female population of 29.45 million females, one can estimate a crude prevalence of 17 TS per 100,000 females (1 per 5,882 females), corresponding to 34% of the expected prevalence (Schoemaker et al., 2008b).”
BackgroundResultInfluentialPrenatal and postnatal prevalence of Turner's syndrome: a registry study
Gravholt, C. H., Juul, S., Naeraa, R. W., & Hansen, J. (1996) · BMJ · doi:10.1136/bmj.312.7022.16 · Cited by 187
Self-citationThe Turner syndrome life course project: karyotype-phenotype analyses across the lifespan
Cameron‐ Pimblett, A., La Rosa, C., King, T. F. J., Davies, M. C., & Conway, G. S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13394 · Cited by 161
Jeon, K. C., Chen, L.-S., & Goodson, P. (2012) · Genetics in Medicine · doi:10.1038/gim.0b013e31822e57a7 · Cited by 139
Ji, J., Zöller, B., Sundquist, J., & Sundquist, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.30126 · Cited by 116 · cited 21×
“a significant increased risk was found for benign CNS tumors (meningiomas and astrocytomas) and nervous system cancer (Ji et al., 2016; Schoemaker et al., 2008a) as well for gastrointestinal cancer (Gravholt”
BackgroundResultInfluentialViuff, M. H., Stochholm, K., Uldbjerg, N., Nielsen, B. B., the Danish Fetal Medicine Study Group, & Gravholt, C. H. (2015) · Human Reproduction · doi:10.1093/humrep/dev192 · Cited by 78 · cited 3×
“Of these, 69% of TS pregnancies (n = 81), 48% of KS pregnancies (n = 13), 24% of 47,XXX pregnancies (n = 5), and 29% of 47,XYY pregnancies (n = 2) ended in termination of the pregnancy (Viuff et al., 2015).”
BackgroundSelf-citationSex hormone replacement therapy in Turner syndrome—impact on morbidity and mortality
Viuff, M. H., Berglund, A., Juul, S., Andersen, N. H., Stochholm, K., & Gravholt, C. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz039 · Cited by 62 · cited 8×
“Based on populationbased studies from United Kingdom and Denmark (Bojesen et al., 2004; Higgins et al., 2007; Schoemaker et al., 2008b; Stochholm et al., 2006, 2010a, 2010b; Swerdlow et al., 2001, 2005a, 2005c; Viuff et al., 2020). hemorrhage, other heart disease, and unspecified peripheral vascular disease), respirat…”
BackgroundMethodSelf-citationSocioeconomic parameters and mortality in Turner syndrome
Stochholm, K., Hjerrild, B., Mortensen, K. H., Juul, S., Frydenberg, M., & Gravholt, C. H. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1066 · Cited by 57
Self-citationObstetric outcomes in women with Turner karyotype
Hagman, A., Källén, K., Barrenäs, M.-L., Landin-Wilhelmsen, K., Hanson, C., Bryman, I., & Wennerholm, U.-B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1421 · Cited by 48 · cited 2×
“In Sweden, among 112 women who were diagnosed with TS during 1973–2007 and were giving birth, 45% (n = 50) were reported with a 45,X/46,XX karyotype (Hagman et al., 2011).”
BackgroundMurdock, D. R., Donovan, F. X., Chandrasekharappa, S. C., Banks, N., Bondy, C., Muenke, M., & Kruszka, P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3414 · Cited by 34
Zelinska, N., Shevchenko, I., & Globa, E. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.5119 · Cited by 21
Cited by
The changing face of Turner syndrome
Gravholt, C. H., Viuff, M., Just, J., Sandahl, K., Brun, S., van der Velden, J., Andersen, N. H., & Skakkebaek, A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac016 · Cited by 149
Hui, L., Ellis, K., Mayen, D., Pertile, M. D., Reimers, R., Sun, L., Vermeesch, J., Vora, N. L., & Chitty, L. S. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6357 · Cited by 109
Martin‐Giacalone, B. A., Lin, A. E., Rasmussen, S. A., Kirby, R. S., Nestoridi, E., Liberman, R. F., Agopian, A. J., Carey, J. C., Cragan, J. D., Forestieri, N., et al. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63181 · Cited by 28
“Another limitation of the current Turner syndrome literature is the exclusion of non-live birth outcomes (Berglund et al., 2020; Gravholt et al., 2022; Stochholm et al., 2006), which can result in underestimates of some severe birth defects (Heinke et al.”
BackgroundMartel, R. A., Blakemore, J. K., & Fino, M. E. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02469-1 · Cited by 17
“Turner syndrome is an example of a common sex chromosome disorder with a prevalence of approximately 1 in 2,000 females [2].”
Patterns of psychopathology and cognition in sex chromosome aneuploidy
Rau, S., Whitman, E. T., Schauder, K., Gogate, N., Lee, N. R., Kenworthy, L., & Raznahan, A. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09407-9 · Cited by 14
“Expansion of SCA cohort sizes in future research will enable adequately powered statistical comparisons of carriers diagnosed prenatally vs those diagnosed postnatally, which can help to provide a proxy for potential ascertainment biases [70].”
Background
Metadata
- Authors
- Berglund, A., Stochholm, K., & Gravholt, C. H.
- Venue
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Publisher
- Wiley
- Published
- 2020-06
- Volume
- 184
- Issue
- 2
- Pages
- 202-215
- ISSN
- 1552-4868 (ISSN-L)
- 1552-4876
- OpenAlex
- W3032944456
- Cited by
- 139
- References
- 18
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.